Cargando…
Modulation of cathepsin G expression in severe atopic dermatitis following medium-dose UVA1 phototherapy
BACKGROUND: During the last decade, medium-dose UVA1 phototherapy (50 J/cm(2)) has achieved great value within the treatment of severe atopic dermatitis (AD). The purpose of our study was to investigate to what extent UVA1 irradiation is able to modulate the status of protease activity by the use of...
Autores principales: | Breuckmann, Frank, von Kobyletzki, Gregor, Avermaete, Annelies, Kreuter, Alexander, Altmeyer, Peter, Gambichler, Thilo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC126230/ https://www.ncbi.nlm.nih.gov/pubmed/12204095 |
Ejemplares similares
-
UVA/UVA1 phototherapy and PUVA photochemotherapy in connective tissue diseases and related disorders: a research based review
por: Breuckmann, Frank, et al.
Publicado: (2004) -
The impact of medium dose UVA1 phototherapy on pruritus, DLQI and SCORAD index in patients with atopic dermatitis
por: Malinowska, Karolina, et al.
Publicado: (2019) -
Modern Aspects of Phototherapy for Atopic Dermatitis
por: Grundmann, Sonja Alexandra, et al.
Publicado: (2012) -
Serum folate levels after UVA exposure: a two-group parallel randomised controlled trial
por: Gambichler, Thilo, et al.
Publicado: (2001) -
Impact of UVA exposure on psychological parameters and circulating serotonin and melatonin
por: Gambichler, Thilo, et al.
Publicado: (2002)